Anti-tumor Efficacy Assessment of the Sigma Receptor Pan Modulator RC-106. A Promising Therapeutic Tool for Pancreatic Cancer
Conclusions Overall, our data evidenced that the pan-SR modulator RC-106 is an optimal candidate for in vivo studies in animal models of PC.
Source: Frontiers in Pharmacology - Category: Drugs & Pharmacology Source Type: research
More News: Biology | Cancer | Cancer & Oncology | Chemotherapy | Drugs & Pharmacology | Pancreas | Pancreatic Cancer | Study